Skip to main content

Advertisement

SpringerLink
Log in

Aspirin in secondary prevention of recurrent venous thromboembolism

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Vandvik PO, Lincoff AM, Gore JM, Gutterman DD, Sonnenberg FA, Alonso-Coello P et al (2012) Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e637S–e668S

    PubMed Central  CAS  PubMed  Google Scholar 

  2. Antiplatelet Trialists’ Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy–III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 308(6923):235–246

    Article  Google Scholar 

  3. Pulmonary Embolism Prevention (PEP) trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355(9212):1295–1302

    Article  Google Scholar 

  4. Undas A, Brummel-Ziedins K, Mann KG (2014) Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid. J Thrombo Haemost 12(11):1776–1787

    Article  CAS  Google Scholar 

  5. Steele P (1980) Trial of dipyridamole-aspirin in recurring venous thrombosis. Lancet 2(8208–8209):1328–1329

    Article  CAS  PubMed  Google Scholar 

  6. Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M et al (2012) Aspirin for preventing the recurrence of venous thromboembolism. New Engl J Med 366(21):1959–1967

    Article  CAS  PubMed  Google Scholar 

  7. Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P et al (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. New Engl J Med 367(21):1979–1987

    Article  CAS  PubMed  Google Scholar 

  8. Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R et al (2014) Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation 130(13):1062–1071

    Article  CAS  PubMed  Google Scholar 

  9. Milan M, Noventa F, Ghirarduzzi A, Pengo V, Vedovetto V, Filippi L et al (2012) Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis: retrospective cohort study. J Thrombo Haemost 10(10):2205–2206

    Article  CAS  Google Scholar 

  10. Schulman S, Granqvist S, Holmstrom M, Carlsson A, Lindmarker P, Nicol P, The Duration of Anticoagulation Trial Study Group et al (1997) The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. New Engl J Med 336(6):393–398

    Article  CAS  PubMed  Google Scholar 

  11. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR et al (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New Engl J Med 340(12):901–907

    Article  CAS  PubMed  Google Scholar 

  12. Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Warfarin Optimal Duration Italian Trial Investigators et al (2001) Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. New Engl J Med 345(3):165–169

    Article  CAS  PubMed  Google Scholar 

  13. Agnelli G, Prandoni P, Becattini C, Silingardi M, Taliani MR, Miccio M et al (2003) Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 139(1):19–25

    Article  CAS  PubMed  Google Scholar 

  14. Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P (2007) The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 147(11):766–774

    Article  PubMed  Google Scholar 

  15. Kahn SR, Shbaklo H, Lamping DL, Holcroft CA, Shrier I, Miron MJ et al (2008) Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 6(7):1105–1112

    Article  CAS  PubMed  Google Scholar 

  16. Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA et al (2014) The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the american heart association. Circulation 130(18):1636–1661

    Article  PubMed  Google Scholar 

  17. Prandoni P, Prins MH, Lensing AW, Ghirarduzzi A, Ageno W, Imberti D et al (2009) Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med 150(9):577–585

    Article  PubMed  Google Scholar 

  18. Siragusa S, Malato A, Anastasio R, Cigna V, Milio G, Amato C et al (2008) Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the duration of anticoagulation based on compression ultrasonography (DACUS) study. Blood 112(3):511–515

    Article  CAS  PubMed  Google Scholar 

  19. Verhovsek M, Douketis JD, Yi Q, Shrivastava S, Tait RC, Baglin T et al (2008) Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 149(7):481–490 W94

    Article  PubMed  Google Scholar 

  20. Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A, Testa S et al (2010) Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood 115(3):481–488

    Article  CAS  PubMed  Google Scholar 

  21. Investigators E, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H et al (2010) Oral rivaroxaban for symptomatic venous thromboembolism. New Engl J Med 363(26):2499–2510

    Article  Google Scholar 

  22. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M et al (2013) Apixaban for extended treatment of venous thromboembolism. New Engl J Med 368(8):699–708

    Article  CAS  PubMed  Google Scholar 

  23. Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D et al (2013) Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. New Engl J Med 368(8):709–718

    Article  CAS  PubMed  Google Scholar 

  24. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ et al (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e419S–e494S

    PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

    Kochawan Boonyawat

  2. Department of Medicine, McMaster University, Room L208-50 Charlton Ave East, Hamilton, ON, L8N 4A6, Canada

    Mark A. Crowther

Authors
  1. Kochawan Boonyawat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark A. Crowther
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark A. Crowther.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boonyawat, K., Crowther, M.A. Aspirin in secondary prevention of recurrent venous thromboembolism. J Thromb Thrombolysis 39, 392–394 (2015). https://doi.org/10.1007/s11239-015-1196-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-015-1196-4

Keywords

Search

Navigation